Use of Generic Medicines: Challenges and Benefits

被引：6

作者：

Dixi, Avika ^{[1
,2
]}

Kumar, Neeta ^{[3
]}

Kumar, Sanjiv ^{[4
]}

机构：

[1] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA

[2] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA

[3] Jamia Millia Islamia, Fac Dent, Dept Pathol, New Delhi, India

[4] Int Inst Hlth Management Res, Plot 3,Sect 18A, New Delhi 110075, India

来源：

JOURNAL OF HEALTH MANAGEMENT | 2018年 / 20卷 / 01期

关键词：

Generic drugs; branded drugs; Challenges for generic drugs; fixed drugs combinations; affordable healthcare; healthcare expenditure;

D O I：

10.1177/0972063417747747

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The government is committed to make healthcare affordable as stated in the National Health Policy 2017. An estimated 94 million people in India are pushed into poverty due to expenditure on healthcare. About two thirds of the expenditure is incurred on medicines. Generic medicines are as effective as branded medicines. The initiative of the government and Medical Council of India by making it mandatory for doctors to write generic medicines has raised many concerns related to generic drugs availability and quality. Experience in the USA and Canada support the argument in favor of generic medicine. India is the main supplier of the generic medicines to the USA. There is a need to curtail inducement by pharmaceutical companies to promote their branded drugs as is being done in the USA. The government needs to make generic drugs easily available, strengthen quality control and educate doctors on benefits of using generic drugs.

引用

页码：84 / 90

页数：7

共 21 条

[1]

Agencies, 2017, ET HEALTHWORLD 0512

[2] Health industry practices that create conflicts of interest - A policy proposal for academic medical centers [J].

Brennan, TA ;

Rothman, DJ ;

Blank, L ;

Blumenthal, D ;

Chimonas, SC ;

Cohen, JJ ;

Goldman, J ;

Kassirer, JP ;

Kimball, H ;

Naughton, J ;

Smelser, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (04) :429-433

[3]

Garg Charu C., MONITORING FRA UNPUB

[4] Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis [J].

Kesselheim, Aaron S. ;

Misono, Alexander S. ;

Lee, Joy L. ;

Stedman, Margaret R. ;

Brookhart, M. Alan ;

Choudhry, Niteesh K. ;

Shrank, William H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2514-2526

[5] The backlash against bioequivalence and the interchangeability of brand-name and generic drugs [J].

Kesselheim, Aaron S. .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12) :1350-1351

[6] Business Model-Related Conflict of Interests in Medicine Problems and Potential Solutions [J].

Larkin, Ian ;

Loewenstein, George .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (17) :1745-1746

[7]

Medical Council of India, 2017, MCI2112GEN2017ETHICS

[8]

Medicine Survey-Core Expert Committee, 2016, SURV EXT PROBL SPUR

[9]

Ministry of Health and Family Welfare, 2016, COMPL LIST 344 MED B

[10]

Ornstein C, 2016, DOLLARS FOR DOCS

← 1 2 3 →